Quince Therapeutics

Quince TherapeuticsQuince Therapeutics (fka Cortexyme) is a late-stage biotechnology company dedicated to unlocking the ...

Sequoia

What they do

Problem

Patients with rare diseases lack effective treatments that leverage their own biology to address underlying causes.

Solution

It develops late-stage biotechnology therapies designed to harness a patient’s own biology to treat rare diseases.

Who it's for

Patients with rare diseases and the clinicians and hospitals that treat them.